Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16436-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16436-1-AP, RRID:AB_2102499
- Product name
- FARS2 antibody
- Antibody type
- Polyclonal
- Description
- FARS2 antibody (Cat. #16436-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Clinical and molecular characterization of novel FARS2 variants causing neonatal mitochondrial disease.
Phenylalanine impairs insulin signaling and inhibits glucose uptake through modification of IRβ.
Novel FARS2 variants in patients with early onset encephalopathy with or without epilepsy associated with long survival.
New insights into the phenotype of FARS2 deficiency.
Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiency.
Chen W, Rehsi P, Thompson K, Yeo M, Stals K, He L, Schimmel P, Chrzanowska-Lightowlers ZMA, Wakeling E, Taylor RW, Kuhle B
Molecular genetics and metabolism 2023 Nov;140(3):107657
Molecular genetics and metabolism 2023 Nov;140(3):107657
Phenylalanine impairs insulin signaling and inhibits glucose uptake through modification of IRβ.
Zhou Q, Sun WW, Chen JC, Zhang HL, Liu J, Lin Y, Lin PC, Wu BX, An YP, Huang L, Sun WX, Zhou XW, Li YM, Yuan YY, Zhao JY, Xu W, Zhao SM
Nature communications 2022 Jul 25;13(1):4291
Nature communications 2022 Jul 25;13(1):4291
Novel FARS2 variants in patients with early onset encephalopathy with or without epilepsy associated with long survival.
Barcia G, Rio M, Assouline Z, Zangarelli C, Roux CJ, de Lonlay P, Steffann J, Desguerre I, Munnich A, Bonnefont JP, Boddaert N, Rötig A, Metodiev MD, Ruzzenente B
European journal of human genetics : EJHG 2021 Mar;29(3):533-538
European journal of human genetics : EJHG 2021 Mar;29(3):533-538
New insights into the phenotype of FARS2 deficiency.
Vantroys E, Larson A, Friederich M, Knight K, Swanson MA, Powell CA, Smet J, Vergult S, De Paepe B, Seneca S, Roeyers H, Menten B, Minczuk M, Vanlander A, Van Hove J, Van Coster R
Molecular genetics and metabolism 2017 Dec;122(4):172-181
Molecular genetics and metabolism 2017 Dec;122(4):172-181
Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiency.
Almalki A, Alston CL, Parker A, Simonic I, Mehta SG, He L, Reza M, Oliveira JM, Lightowlers RN, McFarland R, Taylor RW, Chrzanowska-Lightowlers ZM
Biochimica et biophysica acta 2014 Jan;1842(1):56-64
Biochimica et biophysica acta 2014 Jan;1842(1):56-64
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The FARS2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human FARS2. This antibody recognizes human, mouse, rat antigen. The FARS2 antibody has been validated for the following applications: ELISA, WB analysis.
